His scientific interests lie mostly in Asthma, Immunology, Allergy, Pathology and Lung. Antoine Magnan has included themes like Placebo, Pediatrics and Intensive care medicine in his Asthma study. His Intensive care medicine research is multidisciplinary, incorporating elements of Inhaler and Inhalation.
His Immunology study incorporates themes from Gastroenterology and Platelet-derived growth factor receptor. His work focuses on many connections between Allergy and other disciplines, such as Immunoglobulin E, that overlap with his field of interest in Allergic inflammation and Hygiene hypothesis. Antoine Magnan has researched Pathology in several fields, including Lung transplantation, Bronchiolitis obliterans, Respiratory disease and Extracellular matrix.
Antoine Magnan mainly investigates Immunology, Asthma, Allergy, Internal medicine and Lung. His Immunology research focuses on Immune system, House dust mite, Immunoglobulin E, T cell and Inflammation. His studies deal with areas such as Respiratory disease, Exacerbation, Intensive care medicine, Omalizumab and Physical therapy as well as Asthma.
His research integrates issues of Sensitization and Immunotherapy in his study of Allergy. Antoine Magnan studied Internal medicine and Placebo that intersect with Randomized controlled trial. His study looks at the intersection of Lung and topics like Pathology with Bronchoalveolar lavage.
The scientist’s investigation covers issues in Immunology, Asthma, Internal medicine, Lung transplantation and Lung. His studies in Immune system, Allergy, House dust mite, Immunoglobulin E and Inflammation are all subfields of Immunology research. His Asthma research is multidisciplinary, incorporating perspectives in Chemokine and Health care.
In his research, Sinusitis, Benralizumab, Asthma Control Questionnaire, Spirometry and Inhalation is intimately related to Placebo, which falls under the overarching field of Internal medicine. His study in Lung transplantation is interdisciplinary in nature, drawing from both Biomarker, T cell, Incidence and Oncology. His Lung research integrates issues from Cancer research, Pneumonia, Gastroenterology, Kinase and Transplantation.
His primary areas of study are Asthma, Internal medicine, Intensive care medicine, Severe asthma and Allergy. His research in Asthma intersects with topics in Visual analogue scale, Physical therapy, Inflammation and Health care. The study of Internal medicine is intertwined with the study of Inhalation in a number of ways.
His Intensive care medicine research is multidisciplinary, relying on both Tertiary care, Endotype, Lung injury and Referral. His study focuses on the intersection of Severe asthma and fields such as Asthma control with connections in the field of Pediatrics, Cohort, Exacerbation, Cohort study and Observational study. Allergy is a primary field of his research addressed under Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
Federico Lavorini;Antoine Magnan;Antoine Magnan;Jean Christophe Dubus;Thomas Voshaar.
Respiratory Medicine (2008)
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
Geoffrey L Chupp;Eric S Bradford;Frank C Albers;Daniel J Bratton.
The Lancet Respiratory Medicine (2017)
Importance of inhaler devices in the management of airway disease
J.C. Virchow;G.K. Crompton;R. Dal Negro;S. Pedersen.
Respiratory Medicine (2008)
Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients.
M Humbert;G Monti;M Fartoukh;A Magnan.
European Respiratory Journal (1998)
The need to improve inhalation technique in Europe: A report from the Aerosol Drug Management Improvement Team
G.K. Crompton;P.J. Barnes;M. Broeders;C. Corrigan.
Respiratory Medicine (2006)
Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma.
Antoine O. Magnan;Laurent G. Mély;Christophe A. Camilla;Monique M. Badier.
American Journal of Respiratory and Critical Care Medicine (2000)
IL-17 in severe asthma. Where do we stand?
Julie Chesné;Faouzi Braza;Guillaume Mahay;Sophie Brouard.
American Journal of Respiratory and Critical Care Medicine (2014)
Allergic vs nonallergic asthma: what makes the difference?
Stéphanie Romanet-Manent;D Charpin;A Magnan;A Lanteaume.
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski.
A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma
Gilles Garcia;Gilles Garcia;Antoine Magnan;Antoine Magnan;Raphaël Chiron;Cécile Contin-Bordes;Cécile Contin-Bordes.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: